DP-13

N/A

Report date: 2022/12/17 23:45:53
NME

Base Information

Drug NameDP-13
Drug Alias NameDP-13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 11B2 inhibitors
TargetsCytochrome P450 11B2
Therapy Area/IndicationsHyperaldosteronism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDamian Pharma
China Registration ClassN/A

Develop Information

Active CompaniesDamian Pharma Ag
Inactive CompaniesN/A
Active IndicationsHyperaldosteronism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A